MARKET

NUVA

NUVA

NuVasive
NASDAQ

Real-time Quotes | Nasdaq Last Sale

56.80
-0.13
-0.23%
After Hours: 56.80 0 0.00% 16:43 01/25 EST
OPEN
56.61
PREV CLOSE
56.93
HIGH
56.98
LOW
55.39
VOLUME
587.42K
TURNOVER
--
52 WEEK HIGH
81.00
52 WEEK LOW
28.55
MARKET CAP
2.91B
P/E (TTM)
-260.9095
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
$ 21.6 Billion Orthopedic Biomaterials Market – Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2027
Jan 25, 2021 (Market Insight Reports) -- The global Orthopedic Biomaterials market is expected to grow at a CAGR of around 7.1% over the forecast period 2020...
Market Insight Reports · 10h ago
Scaffold Technology Market Size, Share and Trend to Hit $ 1,508.2 Mn by 2025 - Industry News
Jan 25, 2021 (Market Insight Reports) -- Global scaffold technology market is expected to accumulate a valuation of $1,508.2 million by 2025, according to...
Market Insight Reports · 18h ago
Prosthetic Disc Nucleus Market Size,Growth, Share Global Development and Forecast, Top Companies, Industry Current Trends, Application, Growth Factors to 2026 Research Report
Jan 25, 2021 (The Expresswire) -- Global Prosthetic Disc Nucleus Market Research Report features an extensive study of the current market landscape and...
The Express Wire · 23h ago
Bone Grafts and Substitutes Market Analysis with Key Players, Applications, Trends and Forecasts to 2026
Market Insight Reports · 23h ago
Spinal Devices Market Segmentation 2021-2025, Product Definition, Market Share and Characteristics, Company Profiles, Product Sales, Top Revenues and SWOT Analysis
The Express Wire · 23h ago
The impact of COVID-19 on Artificial Bone Market 2026 Global Size, Key Companies, Trends, Growth and Regional Forecasts Research
Jan 25, 2021 (The Expresswire) -- The report provides revenue of the global Artificial Bone market for the period 2016 and 2025, considering 2019 as the base...
The Express Wire · 1d ago
Orthopedic Devices Market to cross $ 67.2 Billion by 2027 at 4.4% CAGR
Jan 23, 2021 (Market Insight Reports) -- NEW YORK – Nova One Advisor predicts, The global Orthopedic Devices market is estimated to be valued at nearly US$...
Market Insight Reports · 2d ago
Orthopedics & Trauma Implants Market 2021 : Top Countries Data with Drivers and Restraints, Business Opportunities, Advancement Technologies and Forecast to 2026
Jan 21, 2021 (The Expresswire) -- Global “Orthopedics and Trauma Implants Market" 2021-2026 Research Report provides key analysis on the market status of the...
The Express Wire · 4d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NUVA. Analyze the recent business situations of NuVasive through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 19 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average NUVA stock price target is 61.24 with a high estimate of 76.00 and a low estimate of 48.00.
EPS
Institutional Holdings
Institutions: 447
Institutional Holdings: 58.11M
% Owned: 113.30%
Shares Outstanding: 51.28M
TypeInstitutionsShares
Increased
85
3.83M
New
74
-1.68M
Decreased
101
4.45M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.50%
Healthcare Equipment & Supplies
+0.73%
Key Executives
Chairman/Director
Gregory Lucier
Chief Executive Officer/Director
J. Christopher Barry
Chief Financial Officer/Executive Vice President
Matthew Harbaugh
Chief Human Resource Officer
Lucas Vitale
Executive Vice President
Brent Boucher
Executive Vice President
Massimo Calafiore
Senior Vice President/General Counsel/Secretary
Nathaniel Sisitsky
Senior Vice President
Dale Wolf
Independent Director
Vickie Capps
Independent Director
John DeFord
Independent Director
Robert Friel
Independent Director
R. Scott Huennekens
Independent Director
Leslie Norwalk
Independent Director
Donald Rosenberg
Independent Director
Daniel Wolterman
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About NUVA
Nuvasive, Inc. is a medical device company. The Company focuses on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine surgery. Its product portfolio focuses on applications for spine fusion surgery, including biologics used to aid in the spinal fusion process. Its principal product offering includes a minimally-disruptive surgical platform called Maximum Access Surgery (MAS). The platform includes its software-driven nerve detection and avoidance systems, including NVM5, and intraoperative monitoring services and support; MaXcess, an integrated split-blade retractor system, and a range of implants and biologics. The platform combines three product categories: its MaXcess retractors, specialized implants and fixation products, and nerve monitoring systems and service offerings that collectively enable surgeons to detect and navigate around nerves, while directing customized access to the spine for implant delivery.
More

Webull offers kinds of NuVasive, Inc. stock information, including NASDAQ:NUVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NUVA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NUVA stock methods without spending real money on the virtual paper trading platform.